𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients

✍ Scribed by Dr. Stimson P. Schantz; T. C. Hsu


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
615 KB
Volume
11
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


The expression of chromosome breakage as a response to mutagen exposure may contribute to the development of head and neck cancer. Lymphocytes from 46 previously untreated head and neck cancer patients were cultured in vitro and exposed to the radiomimetic clastogen, bleomycin. The lymphocytes were then arrested in metaphase and analyzed for bleomycin-induced chromosome breaks. Mean bleomycin-induced chromosome breaks per cell (b/c) in head and neck cancer patients (0.94 2 0.3 b/c) were significantly higher than in either controls (0.70 * 0.3 b/c; p < 0.001) or a concurrently examined patient population with central nervous system tumors (0.55 -t 0.3 b/c; p < 0.001). The expression of mutagen-induced chromosome fragility in the head and neck cancer population was site-specific, being most evident in patients with laryngeal or pharyngeal cancer but not oral cavity disease. The differential responses to mutagen effects may be a reflection of DNA repair deficiency. Head and neck cancer patients express a higher degree of chromosomal mutagen sensitivity, which may contribute to neoplastic development. HEAD & NECK 11:337-342, 1989 Studies on chromosome instability in some individuals suggest that such a phenotype may have


πŸ“œ SIMILAR VOLUMES


Spontaneous apoptosis of tumor-specific
✍ Andreas E. Albers; Carsten Schaefer; Carmen Visus; William Gooding; Albert B. De πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 2 views

## Abstract ## Background In cancer, tumor escape from the host immune system includes apoptosis of circulating CD3^+^CD8^+^ effector T lymphocytes. Here, we compare sensitivity to apoptosis of virus‐ with tumor‐specific circulating CD8^+^ T cells in patients with head and neck cancer. ## Methods

Increased presence of CD34+ cells in the
✍ Thomas Garrity; Rajiv Pandit; Mark A. Wright; Janet Benefield; Sarita Keni; M. R πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 181 KB πŸ‘ 2 views

Patients with head and neck squamous cell carcinoma (HNSCC) have profound immune deficiencies. In 65% of these patients, there is an increased intra-tumoral presence of immune-suppressive CD34 Ψ‰ progenitor cells. The goal of the present study was to determine whether CD34 Ψ‰ cell levels were also inc